# Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal Haemangioma

> **NCT03571282** · EARLY_PHASE1 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 50 (estimated)

## Conditions studied

- Circumscribed Choroidal Haemangioma

## Interventions

- **DRUG:** conbercept

## Key facts

- **NCT ID:** NCT03571282
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-06
- **Primary completion:** 2019-06-06
- **Final completion:** 2019-06-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03571282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03571282, "Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal Haemangioma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03571282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*